4//SEC Filing
Slapak Christopher 4
Accession 0001209191-22-006810
CIK 0001817229other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:36 PM ET
Size
5.4 KB
Accession
0001209191-22-006810
Insider Transaction Report
Form 4
Slapak Christopher
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-02-01+116,000→ 116,000 totalExercise: $8.63Exp: 2032-01-31→ Common Stock (116,000 underlying)
Footnotes (1)
- [F1]This option vests over four years in equal monthly installments beginning on February 1, 2022.
Documents
Issuer
Vor Biopharma Inc.
CIK 0001817229
Entity typeother
Related Parties
1- filerCIK 0001841150
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 4:36 PM ET
- Size
- 5.4 KB